ACB Aurora Cannabis Inc.
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes Aurora, Being, CanniMed, CraftPlant, Daily Special, Drift, Greybeard, IndiMed, MedReleaf, Pedanios, San Raf, Tasty's, Whistler, and WMMC. The company also engages in pharmacy activities. Aurora Cannabis Inc. was founded in 2013 and is headquartered in Edmonton, Canada.…
Industry Peers
Drug Manufacturers - Specialty & GenericKey Statistics
About Aurora Cannabis (NASDAQ: ACB)
›
Aurora Cannabis (NASDAQ: ACB) is listed on Nasdaq, where its shares trade in USD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 1,028 employees.
The shares were at 4.940 USD on 13 November 2026, up 9.1% over 52 weeks. Its 52-week range is 2.560 USD to 6.360 USD: the price is 22.3% below the high and 93.0% above the low.
Its market capitalisation is 324.78M USD.
Aurora Cannabis reports return on equity of -26.6%, an operating margin of -13.8% and revenue down 8.8% year over year.
It holds more cash than debt, a net cash position of 77.34M CAD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. The next earnings report is expected on 3 February 2027.